Zhaofei Liu

18PUBLICATIONS
46CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 15, 2026
Nano-enabled spatially selective protein degradation modulates lactate metabolism to potentiate antitumor immunity in liver cancer.

|Dec 19, 2025
ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy.

Rui Song, Meixin Zhao, Ting Zhang

|Oct 07, 2025
Tumors with microsatellite instability upregulate TREX1 to escape antitumor immunity.

Yan Xu, Zheqi Zhou, Wenzheng Chen

|Mar 24, 2025
A Nanoradiosensitizer Potentiates Tumor Radiotherapy through JFK Inhibition and Hypoxia Alleviation.

Jianze Wang, Qianrui Guo, Lin He

|Oct 10, 2024
<sup>68</sup>Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trial.

Xiuling Shen, Haoyi Zhou, Xin Zhou

|Jun 23, 2024
Targeted protein degradation combined with PET imaging reveals the role of host PD-L1 in determining anti-PD-1 therapy efficacy.

Jinhong Du, Shu Han, Haoyi Zhou

Pageof 3

Frequent Collaborators

4 joint publications

Zhi Yang

3 joint publications

Jinhong Du

2 joint publications

Fan Wang

1 joint publications

Xiaoyuan Chen